Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-01-08 @ 11:57 PM
Study NCT ID:
NCT02175433
Status:
COMPLETED
Last Update Posted:
2024-11-01
First Post:
2014-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-29
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-24
First Submit QC Date:
None
Study First Post Date:
2014-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-30
Last Update Post Date:
2024-11-01
Last Update Post Date Type:
ACTUAL